Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Singer

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Scientific Reports|March 15, 2019
Prognostic Impact of Carboxylesterase 2 in CholangiocarcinomaBenjamin Goeppert, Marcus Renner, Stephan Singer, et al.
Hepatology (Baltimore, Md.)|May 7, 2014
Prosurvival function of the cellular apoptosis susceptibility/importin-α1 transport cycle is repressed by p53 in liver cancerJuliane Winkler, Alessandro Ori, Kerstin Holzer, et al.
Cancers|December 11, 2022
Immunophenotyping of Circulating and Intratumoral Myeloid and T Cells in Glioblastoma PatientsSascha Marx, Fabian Wilken, Lea Miebach, et al.
Diagnostic Pathology|May 10, 2019
Low frequency of mismatch repair deficiency in gallbladder cancerBenjamin Goeppert, Stephanie Roessler, Marcus Renner, et al.
European Journal of Pediatrics|December 14, 2025
Endoscopic retrograde cholangiopancreatography as a diagnostic key tool for biliary atresia: feasibility, safety and accuracy in neonates with cholestatic liver diseaseSteffen Hartleif, Michael Esser, Jörg Fuchs, et al.
Hepatology (Baltimore, Md.)|November 21, 2017
Cytoplasmic localization of the cell polarity factor scribble supports liver tumor formation and tumor cell invasivenessShan Wan, Anne-Sophie Meyer, Sofia Maria Elisabeth Weiler, et al.
Oncogene|February 15, 2020
NOTCH target gene HES5 mediates oncogenic and tumor suppressive functions in hepatocarcinogenesisSarah Luiken, Angelika Fraas, Matthias Bieg, et al.
Nature Communications|May 16, 2019
Nucleoporin Nup155 is part of the p53 network in liver cancerKerstin Holzer, Alessandro Ori, Amy Cooke, et al.
Virchows Archiv : an International Journal of Pathology|December 16, 2019
HER2 gene (ERBB2) amplification is a low-frequency driver with potential predictive value in gallbladder carcinomaThomas Albrecht, Melina Rausch, Stephanie Roessler, et al.
EMBO Molecular Medicine|February 3, 2025
An AI-assisted morphoproteomic approach is a supportive tool in esophagitis-related precision medicineSven Mattern, Vanessa Hollfoth, Eyyub Bag, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Scientific Reports|March 15, 2019
Prognostic Impact of Carboxylesterase 2 in CholangiocarcinomaBenjamin Goeppert, Marcus Renner, Stephan Singer, et al.
Hepatology (Baltimore, Md.)|May 7, 2014
Prosurvival function of the cellular apoptosis susceptibility/importin-α1 transport cycle is repressed by p53 in liver cancerJuliane Winkler, Alessandro Ori, Kerstin Holzer, et al.
Cancers|December 11, 2022
Immunophenotyping of Circulating and Intratumoral Myeloid and T Cells in Glioblastoma PatientsSascha Marx, Fabian Wilken, Lea Miebach, et al.
Diagnostic Pathology|May 10, 2019
Low frequency of mismatch repair deficiency in gallbladder cancerBenjamin Goeppert, Stephanie Roessler, Marcus Renner, et al.
European Journal of Pediatrics|December 14, 2025
Endoscopic retrograde cholangiopancreatography as a diagnostic key tool for biliary atresia: feasibility, safety and accuracy in neonates with cholestatic liver diseaseSteffen Hartleif, Michael Esser, Jörg Fuchs, et al.
Hepatology (Baltimore, Md.)|November 21, 2017
Cytoplasmic localization of the cell polarity factor scribble supports liver tumor formation and tumor cell invasivenessShan Wan, Anne-Sophie Meyer, Sofia Maria Elisabeth Weiler, et al.
Oncogene|February 15, 2020
NOTCH target gene HES5 mediates oncogenic and tumor suppressive functions in hepatocarcinogenesisSarah Luiken, Angelika Fraas, Matthias Bieg, et al.
Nature Communications|May 16, 2019
Nucleoporin Nup155 is part of the p53 network in liver cancerKerstin Holzer, Alessandro Ori, Amy Cooke, et al.
Virchows Archiv : an International Journal of Pathology|December 16, 2019
HER2 gene (ERBB2) amplification is a low-frequency driver with potential predictive value in gallbladder carcinomaThomas Albrecht, Melina Rausch, Stephanie Roessler, et al.
EMBO Molecular Medicine|February 3, 2025
An AI-assisted morphoproteomic approach is a supportive tool in esophagitis-related precision medicineSven Mattern, Vanessa Hollfoth, Eyyub Bag, et al.
Pageof 10